Tenax Capital Lease Obligations from 2010 to 2025

TENX Stock  USD 6.27  0.09  1.46%   
Tenax Therapeutics Capital Lease Obligations yearly trend continues to be fairly stable with very little volatility. Capital Lease Obligations will likely drop to 0.00 in 2025. Capital Lease Obligations is the total obligations of Tenax Therapeutics under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. View All Fundamentals
 
Capital Lease Obligations  
First Reported
2019-03-31
Previous Quarter
0.0
Current Value
0.0
Quarterly Volatility
113.2 K
 
Covid
Check Tenax Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Tenax Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 8.3 K, Other Operating Expenses of 8.4 M or Research Development of 13.3 M, as well as many indicators such as Price To Sales Ratio of 141.3 K, Dividend Yield of 3.31 or PTB Ratio of 10.79. Tenax financial statements analysis is a perfect complement when working with Tenax Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Tenax Therapeutics Correlation against competitors.
For more information on how to buy Tenax Stock please use our How to Invest in Tenax Therapeutics guide.

Latest Tenax Therapeutics' Capital Lease Obligations Growth Pattern

Below is the plot of the Capital Lease Obligations of Tenax Therapeutics over the last few years. Tenax Therapeutics capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Tenax Therapeutics asset purchases. For example, Tenax Therapeutics can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Tenax Therapeutics control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. Tenax Therapeutics' Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Tenax Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Capital Lease Obligations10 Years Trend
Slightly volatile
   Capital Lease Obligations   
       Timeline  

Tenax Capital Lease Obligations Regression Statistics

Arithmetic Mean140,754
Geometric Mean0.00
Coefficient Of Variation57.96
Mean Deviation62,830
Median171,732
Standard Deviation81,582
Sample Variance6.7B
Range290.8K
R-Value(0.54)
Mean Square Error5B
R-Squared0.29
Significance0.03
Slope(9,286)
Total Sum of Squares99.8B

Tenax Capital Lease Obligations History

2023null
2022183.6 K
2021290.8 K
202060.4 K

About Tenax Therapeutics Financial Statements

Tenax Therapeutics investors use historical fundamental indicators, such as Tenax Therapeutics' Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Tenax Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Tenax Stock Analysis

When running Tenax Therapeutics' price analysis, check to measure Tenax Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenax Therapeutics is operating at the current time. Most of Tenax Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenax Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenax Therapeutics' price. Additionally, you may evaluate how the addition of Tenax Therapeutics to your portfolios can decrease your overall portfolio volatility.